BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37043769)

  • 1. Associations between serum clusterin levels and non-alcoholic fatty liver disease.
    Wang Y; Shen Y; Hu T; Wang Y; Ma X; Yu H; Bao Y
    Endocr Connect; 2023 Jul; 12(7):. PubMed ID: 37043769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals.
    Xu Y; Ma X; Pan X; He X; Wang Y; Bao Y
    Liver Int; 2019 Mar; 39(3):568-574. PubMed ID: 30554468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Ahn SH; Seo DH; Kim SH; Nam MS; Hong S
    Osteoporos Int; 2018 Jan; 29(1):181-190. PubMed ID: 29051986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
    Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
    Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients.
    He X; Shen Y; Ma X; Ying L; Peng J; Pan X; Bao Y; Zhou J
    Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):668-674. PubMed ID: 29574933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk.
    Rodríguez-Calvo R; Moreno-Vedia J; Girona J; Ibarretxe D; Martínez-Micaelo N; Merino J; Plana N; Masana L
    Front Physiol; 2021; 12():781789. PubMed ID: 34966292
    [No Abstract]   [Full Text] [Related]  

  • 11. Higher serum carotenoids associated with improvement of non-alcoholic fatty liver disease in adults: a prospective study.
    Xiao ML; Chen GD; Zeng FF; Qiu R; Shi WQ; Lin JS; Cao Y; Li HB; Ling WH; Chen YM
    Eur J Nutr; 2019 Mar; 58(2):721-730. PubMed ID: 29594435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin is Inversely Associated with Insulin Resistance in Adolescents with Nonalcoholic Fatty Liver Disease.
    Liu B; Zheng H; Liu G; Li Z
    Endocr Metab Immune Disord Drug Targets; 2022; 22(6):631-639. PubMed ID: 34579641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.
    Silaghi CA; Silaghi H; Colosi HA; Craciun AE; Farcas A; Cosma DT; Hancu N; Pais R; Georgescu CE
    Clujul Med; 2016; 89(1):82-8. PubMed ID: 27004029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies].
    Nosov AE; Zenina MT; Gorbushina OY; Baidina AS; Vlasova EM; Alekseev VB
    Ter Arkh; 2021 Aug; 93(8):883-889. PubMed ID: 36286882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
    Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
    Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
    Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
    Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.
    Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Chisari M; Castelli T; Favilla V; Morgia G
    World J Urol; 2015 May; 33(5):743-51. PubMed ID: 25189458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease.
    Pirgon Ö; Bilgin H; Çekmez F; Kurku H; Dündar BN
    J Clin Res Pediatr Endocrinol; 2013; 5(1):33-9. PubMed ID: 23367495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study.
    Hsiao PJ; Lee MY; Wang YT; Jiang HJ; Lin PC; Yang YH; Kuo KK
    BMC Med Genet; 2015 Oct; 16():93. PubMed ID: 26458397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.